Global Neuroblastoma Drug Market – Industry Trends – Forecast to 2026

Global neuroblastoma drug market is rising gradually to an estimated steady CAGR of 4.2% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the growing awareness towards diagnosis and treatment of neuroblastoma cancer, increase in the prevalence of childhood cancers, the rising birth rate, growing medical spending, increasing global healthcare expenditure and technological advancements in pharmaceuticals research.

Leave a Reply

Your email address will not be published. Required fields are marked *